You have not yet registered? Get your account for free.
Forgot Password? We will send you a reset link
17 July 2024
invIOs selects INV501 lead candidate to progress into IND-enabling studies in glioblastoma and melanoma
21 December 2023
invIOs to attend JP Morgan Week in San Francisco in January
9 November 2023
invIOs and Dana-Farber Cancer Institute start collaboration to study novel small molecule INV501 for treatment of glioblastoma
5 September 2023
invIOs starts further clinical trial of APN401, novel cell therapy against solid cancers, and secures major Austrian grant funding
19 June 2023
invIOs presents exciting preclinical data showing that immune-activating small molecule INV501 induces strong cytotoxic activity against solid tumors
18 April 2023
invIOs presents promising new clinical data in solid tumors from autologous cell therapy APN401 at AACR Annual Meeting 2023